Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
HSCSW HEART TEST LABORATORIES INC C/WTS (TO PUR COM)
0.3700.0000.00%
Close
02/08 16:00 ET
High
0.000
Open
0.370
Turnover
107.00
Low
0.000
Pre Close
0.370
Volume
234.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 A.m. Pacific Time
Southlake, Texas, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a medical technology company focused on saving lives by
Heart Test Laboratories (NASDAQ:HSCSW) Stock Price Up 78.2%
Shares of Heart Test Laboratories, Inc. (NASDAQ:HSCSW – Get Rating) rose 78.2% on Friday . The stock traded as high as $0.66 and last traded at $0.42. Approximately 304,444 shares traded hands during
Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th
Southlake, Texas, Jan. 23, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on January 20th, 2023, by HeartSciences (NASDAQ: HSCS; HSCSW), please note that in the second paragrap
HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th
Southlake, Texas, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a medical technology company focused on saving lives by
HeartSciences Appoints David R. Wells to Its Board of Directors, an Experienced Capital Markets and Finance Executive
Southlake, TX, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) ("HeartSciences" or the "Company"), a medical technology company focused on s
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results
Southlake, Texas, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a medical technology company focused on saving lives by
HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms
Southlake, Texas, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a medical technology company focused on saving lives by
HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022
Southlake, Texas, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a medical technology company focused on saving lives by
HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022
Southlake, Texas, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) ("HeartSciences" or the "Company"), a medical technology company focused o
HeartSciences Named as a Top 10 MedTech Startup 2022 by MedTech Outlook Magazine
Southlake, Texas, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) ("HeartSciences" or the "Company"), a medical technology company focused o
Company Overview
More
Heart Test Laboratories, Inc. is a medical technology company focused on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG’s clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.
CEO： Mr. Andrew Simpson ACA
Market： NASDAQ
Listing Date： 06/15/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet